1.34 Lakh New COVID Cases, 2,887 Deaths in India; Tally at 2.84 Cr
Catch all the updates on the coronavirus outbreak here.
India on Thursday, 3 June, reported 1,34,154 new coronavirus cases, taking the tally in the country to 2,84,41,986. The death toll increased by 2,887 to 3,37,989.
According to the Union Health Ministry data, there are currently 17,13,413 active cases across the country, while 2,63,90,584 patients have been discharged so far, with 2,11,499 discharges reported in the last 24 hours.
- Delhi on Thursday reported 487 fresh COVID-19 cases; this is the lowest in over 2.5 months
- Maharashtra on Thursday said that it would be lifting lockdown-like restrictions from Friday in 18 out of 36 districts
- Clinical trials of Bharat Biotech’s Covaxin on children have begun at the All India Institute of Medical Sciences (AIIMS) in Patna
- The Serum Institute of India has applied to the Drug Controller General of India seeking permission to manufacture Sputnik V, reports said on Thursday
- More than 22.10 crore vaccine doses have been administered since India’s inoculation drive began in January
(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)
487 Fresh COVID Cases Reported in Delhi
Delhi records 487 fresh COVID-19 cases; lowest in over 2.5 months and 45 deaths. Meanwhile, the positivity rate has fallen to 0.61 percent.
COVID Lockdown in Karnataka Extended Till 14 June
Karnataka Chief Minister B S Yediyurappa announces extension of COVID-19 lockdown till 14 June.
624 Doctors Have Died During 2nd Wave: IMA
As many as 624 doctors have died during the second wave of the pandemic as of 2 June, the Indian Medical Association said on Thursday.
Serum Institute Applies to DCGI for Permission to Manufacture Sputnik V: Reports
The Serum Instiute of India, which makes the Covishield vaccine, has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture Russia's COVID-19 vaccine Sputnik V, sources were cited as saying by PTI on Thursday.
Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.